Arrivo BioVentures
Arrivo BioVentures is a biopharmaceutical holding company developing first‑of‑its‑kind medicines for hard‑to‑treat diseases. It focuses on targeting the root cause of conditions such as major depressive disorder and severe acute pancreatitis, aiming for meaningful outcomes that extend patients’ lives. The company partners with institutions like the Mayo Clinic and Daiichi Sankyo and is backed by investors including Jazz Pharmaceuticals and Orlando Health Ventures.
Arrivo BioVentures is profiled on the APIs.io network. Tagged areas include Company, Biopharma, Drug Development, Clinical Trials, and Partnerships.
Arrivo BioVentures’ developer surface includes documentation and 3 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Documentation 1
Reference material describing how the API behaves
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Company 1
The organization behind the API
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.